| REXN Shares Outstanding History Table | ||||||||||||||||||||||
Below is a table of the REXN shares outstanding history going back to 5/10/2019:
Also see: REXN Market Cap History REXN YTD Return |
As of 10/29/2020 Rexahn Pharmaceuticals has 4.48 million REXN shares outstanding. Investors often track the REXN shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows REXN share count trends over time, with 10 historical shares outstanding datapoints presented, dating back to 5/10/2019.

| REXN Shares Outstanding History Table | ||||||||||||||||||||||
Below is a table of the REXN shares outstanding history going back to 5/10/2019:
Also see: REXN Market Cap History REXN YTD Return |
| REXN Shares Outstanding History Chart | |||||||||||||||||||||||
REXN Historical Shares Outstanding: +7.69% CAGR
Mouse over chart for data details
| |||||||||||||||||||||||
| REXN Stock Price Chart |
| About Ocuphire Pharma Inc |
| Rexahn Pharmaceuticals is clinical stage biopharmaceutical company developing therapies to improve patient outcomes in cancers. Co.'s pipeline features two oncology product candidates in clinical development and additional compounds in pre-clinical development. Co.'s drug candidates are: RX-3117, which is an investigational oral small molecule nucleoside compound that provides the potential for a targeted anti-cancer therapy; RX-5902, which is a small molecule modulator that modulates the pathway via inhibition of phosphorylated p68 which hinders the transport of beta-catenin into the nucleus and reduces the activation of cancer genes; and RX-0301, which is a potential potent inhibitor. We show 10 historical shares outstanding datapoints in our coverage of REXN's shares outstanding history. Understanding the changing numbers of REXN shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like REXN versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching REXN by allowing them to research REXN shares outstanding history as well as any other stock in our coverage universe. |
| REXN Current Stock Quote |
Quotes delayed 20 minutes Get Dividend Alerts Get SEC Filing Alerts |
| Video: Shares Outstanding Importance | |
|
| REXN Share Performance |
| Shares Outstanding Peers |
| Rexahn Pharmaceuticals (REXN) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
RGEN Shares Outstanding History RGLS Shares Outstanding History RGNX Shares Outstanding History RIGL Shares Outstanding History RLAY Shares Outstanding History RLMD Shares Outstanding History RLYB Shares Outstanding History RMD Shares Outstanding History RMED Shares Outstanding History RMTI Shares Outstanding History More Healthcare companies » |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.2%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.2%.